U.S. Congressmen Call On FDA Commissioner To Press Investigation Into Adulterated Heparin During Upcoming Trip To China
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Calling the blood thinner heparin that was deliberately adulterated in China and exported to American hospitals the worst drug supply contamination in history, two U.S. congressmen are urging the commissioner of FDA to seek resolution of the case during an upcoming trip to China